Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY26 results · Apr–Jun 2025
Pfizer reported revenue from operations of ₹603.05 crore (up 7.1% from Q1 FY25) and net profit of ₹191.75 crore (up 27.2% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a standalone basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 603.05 | 562.86 | +7.1% | 591.91 | +1.9% |
| Other income | 67.17 | 41.84 | +60.5% | 44.58 | +50.7% |
| Total income | 670.22 | 604.70 | +10.8% | 636.49 | +5.3% |
| Profit before tax | 259.53 | 202.62 | +28.1% | 425.80 | −39.0% |
| Net profit for the period | 191.75 | 150.71 | +27.2% | 330.94 | −42.1% |
| EPS, basic (₹) | 41.91 | 32.94 | +27.2% | 72.34 | −42.1% |
| Net margin (%) | 31.8 | 26.8 | 55.9 |
Standalone
- Filed with BSE
- 13 Aug 2025, 17:07 IST
- Board meeting
- 13 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE